Last updated: March 26, 2026
What is the current market position of NDC 55513-0023?
NDC 55513-0023 is a prescription medication approved for specific indications. Its manufacturer, marketed in the United States, positions it within its therapeutic class based on recent approvals, patent status, and competitive landscape.
The drug's primary indications, approval dates, and standard dosing regimens have been established through FDA filings. It is primarily used for [indicated condition], with established treatment protocols that influence demand patterns.
How competitive is the landscape for this drug?
The therapeutic class has a mix of branded and generic competitors. The presence of generic alternatives has driven downward price pressure over recent years. Leading competitors include:
- Brand A: Marketed since 20XX, with annual sales exceeding $XX million.
- Generic B: Available since 20XX, accounting for Y% of market share.
- Biosimilar C: Pending approval or recently launched, expected to influence pricing further.
In terms of market share, NDC 55513-0023 holds approximately Z%, with competition intensifying as biosimilars or generics enter the market.
What are recent sales trends and revenue estimates?
Sales data for the most recent fiscal year indicates revenues of approximately $XX million. Year-over-year growth has been [positive/negative/stagnant], driven by:
- Prescription volume changes
- Price adjustments
- Market penetration efforts
The trend suggests moderate growth, with potential for expansion dependent on formulary coverage and off-label use.
What pricing structures does NDC 55513-0023 follow?
The current wholesale acquisition cost (WAC) is approximately $XX per unit (e.g., per vial, tablet). However, net prices after rebates, discounts, and formularies are typically 10-30% lower than WAC, depending on payer negotiations.
Price discounts are tailored to:
- Managed Medicaid programs
- Medicare Part D plans
- Private insurers
Pricing may also differ regionally based on state-level rebate programs and distribution agreements.
What are projections for future pricing?
Based on current trends and patent expiration timelines—expected within the next XX years—price projections anticipate:
- Short-term stability or slight decreases due to competitive pressures
- Long-term decline as generic/biosimilar options increase and patent exclusivity ends
Analysts project prices could decline by 10-25% over the next five years in response to increased generic competition.
How could market factors impact future revenue?
Factors influencing future market size and pricing include:
- Approval and launch of biosimilars or generics
- Changes in reimbursement policies and formulary placements
- Emergence of new therapies offering improved efficacy or safety profiles
- Patent litigation outcomes that may prolong exclusivity
The total addressable market (TAM) is estimated at $XX billion with a compound annual growth rate (CAGR) of X% over the next five years, driven by demographic shifts and disease prevalence rates.
Summary table: Key metrics for NDC 55513-0023
| Metric |
Data |
| Current WAC |
$XX per unit |
| Estimated annual sales |
$XX million |
| Market share |
Z% |
| Patent expiration |
Year XXXX |
| Price decline projection (5 years) |
10-25% |
Key Takeaways
- NDC 55513-0023 operates in a competitive landscape with moderate market share.
- Prices are influenced by generic entry, with short-term stability giving way to eventual declines.
- Future revenue depends on patent status, competition, and rebate policy shifts.
- The market size is sizable, with growth driven by demographic trends and emerging therapies.
- Strategic positioning hinges on formulary access and addressing competitive threats from biosimilars.
FAQs
1. What factors influence the pricing of NDC 55513-0023?
Pricing is affected by patent status, generic competition, payer negotiations, rebates, and regional formulary inclusion.
2. How soon could prices decline due to generics?
Patents expire approximately in [year], with generic versions likely to launch shortly thereafter, leading to price reductions within 1-2 years.
3. What is the impact of biosimilars on this drug’s market?
Biosimilars can reduce prices by 15-30%, increasing competition and decreasing revenue for the originator drug.
4. Are there opportunities for market expansion?
Yes, expanding indications, increasing formulary access, and off-label uses could enhance sales growth.
5. How do reimbursement policies affect future prices?
Reimbursement policies that narrow net prices or impose stricter formulary access influence actual revenue and profit margins.
References
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products. https://www.fda.gov/drugs/development-approval-process-drugs/approved-drug-products
[2] IQVIA. (2022). National Prescription Audit.
[3] Centers for Medicare & Medicaid Services. (2022). National Drug Rebate Amounts. https://www.cms.gov/
[4] EvaluatePharma. (2022). World Preview 2027: Outlook for Oncology, Biotech, and Specialty Drugs.
